Elanco Animal Health Incorporated (elan)
ELAN Estimates
Public analyst price targets and consensus snapshot for Elanco Animal Health Incorporated. Deeper estimate history and models are available in Vest Terminal.
| Last price | $22.57 |
| Analyst mean target | $31.21 |
| Analyst high target | $34.00 |
| Analyst low target | $26.00 |
| Upside vs mean target | 38.3% |
| Consensus recommendation | Strong Buy |
| Number of analysts | 14 |
| Forward P/E | 17.55 |
Start Free — open ELAN in Vest Terminal
Access live data, filings, ownership, and analysis for Elanco Animal Health Incorporated.
Elanco Animal Health Incorporated FAQ
What does Elanco Animal Health Incorporated (ELAN) do?
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks…
What is ELAN's P/E ratio?
Elanco Animal Health Incorporated has a trailing P/E of N/A× based on publicly available market data.
Does ELAN pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is ELAN in?
Elanco Animal Health Incorporated is classified in Healthcare (Drug Manufacturers - Specialty & Generic) on NYQ.
What is ELAN's market capitalization?
Approximate market cap: $11.27B.
What are the main risks for ELAN?
Key risks include above-average volatility (beta 1.68), among factors on this page.
What are the strengths of ELAN?
Potential positives include revenue growth of 10.2% year-over-year, earnings growth of 4.4% year-over-year.
Where can I get analyst estimates for ELAN?
Public analyst price targets and consensus for Elanco Animal Health Incorporated are on the free /stocks/elan/estimates page. Deeper estimate history and models are available in Vest Terminal.